Souhaitez-vous accéder aux communiqués récents ?

BRANFORD, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, a clinical-stage immuno-oncology company developing a new class of multi-specific T cell engagers with integrated CD2...

- Industry’s First Combination BCMA x GPRC5D In Vivo CAR T Cell Therapy for the Treatment of Multiple Myeloma - SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a...

Asgard Therapeutics to present advanced preclinical data on its lead asset AT-108, a first-in-class, off-the-shelf cancer immunotherapy, at ASGCT 2026

With AI tools demonstrating 85–95% accuracy in biomarker identification and attracting more than $3 billion in recent funding.

PORTLAND and BIDDEFORD, Maine, April 27, 2026 (GLOBE NEWSWIRE) -- From the lasting disruptions of the COVID-19 pandemic to the accelerating impacts of climate change on ecosystems and communities,...

Momentive Software brings home two Stevie Awards - gold for Path LMS and bronze for best research report.

Oncolytics Biotech announced Type C meeting with the FDA aligning on the design of clinical study to support approval of pelareorep in patients with SCAC.

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+...

LEHI, Utah, April 23, 2026 (GLOBE NEWSWIRE) -- SchoolAI, the leading AI learning platform, today released findings from a two-year study conducted in partnership with Jordan School District in Utah,...

Hamilton Global Opportunities (ALHGO) announces initiation of coverage by EuroLand Corporate.